Deals
Aldeyra Therapeutics Raises $7.8M at 21% Premium via Laidlaw & Company
|
Aldeyra Therapeutics (NASDAQ CM:ALDX) announced that it has raised $7,791,560 in a Units (Common Stock + Warrants) transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/244/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Aldeyra Therapeutics (NASDAQ CM:ALDX) announced that it has raised $7,791,560 in a Units (Common Stock + Warrants) transaction.
Capricor Therapeutics (OTC:CAPR) announced that it has raised $9,993,438 in a Common Stock transaction.
Agenus (NASDAQ CM:AGEN) announced that it has raised $35,000,000 in a Common Stock transaction.
HC2 Holdings (OTC:HCHC) announced that it has raised $14,000,000 in a Convertible Preferred Stock transaction.